世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

肝疾患診断薬の世界市場インサイト、2029年までの予測


Global Liver Disease Diagnostics Market Insights, Forecast to 2029

肝疾患診断薬の世界市場は、2023年の133億6,164万米ドルから2029年には201億2,098万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は7.05%と予測されている。 2022年の北米肝疾患診断薬市場規模は50億192... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2023年11月27日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

肝疾患診断薬の世界市場は、2023年の133億6,164万米ドルから2029年には201億2,098万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は7.05%と予測されている。
2022年の北米肝疾患診断薬市場規模は50億1920万米ドル、アジア太平洋地域は30億3697万米ドル、ヨーロッパ肝疾患診断薬は36億9005万米ドルである。2022年における北米の割合は40.95%、APACと欧州はそれぞれ24.78%と30.11%であり、APACの割合は2029年には28.57%に達すると予測され、分析期間を通じて年平均成長率は8.99%である。APACでは中国、日本、韓国、インドが注目すべき市場である。欧州の肝疾患診断薬ランドスケープに関しては、ドイツは2029年までに12億9,290万米ドルに達すると予測され、2023-2029年のCAGRは6.06%であった。

肝疾患診断薬の世界的な主要企業には、ロシュ、アボット、サーモフィッシャーサイエンティフィック、シーメンス・ヘルスイニアーズ、GEヘルスケア、キヤノンメディカルシステムズ、ラボコープ、BD、フィリップスヘルスケアなどがあり、ランドックスラボラトリーズは肝疾患診断薬の世界市場における主要メーカーである。2022年の市場シェアは、売上高上位10社で39.41%を占めた。

レポートの内容
肝疾患診断薬の世界市場規模を概観します。2018年~2022年の過去の市場収益データ、2023年の推定値、2029年までのCAGR予測による世界市場動向の分析。
肝疾患診断薬の主要生産者を調査し、主要地域と国の収益も掲載しています。肝疾患診断薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国に焦点を当てたハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、2018年から2023年までのデータで、肝疾患診断薬の収益、市場シェア、主要企業の業界ランキングに焦点を当てています。世界の肝疾患診断薬市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。

本レポートでは、2018年から2029年までのタイプ別、用途別のセグメントデータ、収益、成長率を分析しています。肝疾患診断薬の収益、予測成長動向、生産技術、用途、エンドユーザー産業の市場規模を評価・予測します。
アボット、ロシュ、サーモフィッシャーサイエンティフィック、ランドックス診断センター、ボストン・サイエンティフィック・コーポレーション、ラボコープ、富士フイルム、堀場製作所、シーメンス・ヘルティニアーズなど、世界の主要企業の詳細な企業プロフィール。

会社別
アボット
ロシュ
サーモフィッシャーサイエンティフィック
ランドックス・ラボラトリーズ
ボストン・サイエンティフィック
ラボコープ
富士フイルム
シーメンス・ヘルスイニアーズ
BD
クックメディカル
GEヘルスケア
フィリップスヘルスケア
キヤノンメディカルシステムズ
キアゲン

タイプ別セグメント
画像検査
血液検査
生検

アプリケーション別
病院および診療所
診断センター
その他

地域別
北米
米国
カナダ
メキシコ
アジア太平洋
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ヨーロッパ
ドイツ
フランス
英国
イタリア
スイス
その他のヨーロッパ
ラテンアメリカ
ブラジル
アルゼンチン
その他のラテンアメリカ
中東・アフリカ
サウジアラビア
アラブ首長国連邦
イスラエル
その他のMEA


ページTOPに戻る


目次

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Liver Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1
1.2.2 Imaging Tests 3
1.2.3 Blood Tests 4
1.2.4 Biopsy 5
1.3 Market by Application 6
1.3.1 Global Liver Disease Diagnostics Market Share by Application: 2018 VS 2022 VS 2029 6
1.3.2 Hospitals and Clinics 8
1.3.3 Diagnostic Centers 9
1.3.4 Others 9
1.4 Assumptions and Limitations 10
1.5 Study Objectives 11
1.6 Years Considered 11
2 Global Growth Trends 13
2.1 Global Liver Disease Diagnostics Market Perspective (2018-2029) 13
2.2 Global Liver Disease Diagnostics Growth Trends by Region 14
2.2.1 Global Liver Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029 15
2.2.2 Liver Disease Diagnostics Historic Market Size by Region (2018-2023) 16
2.2.3 Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029) 17
2.3 Liver Disease Diagnostics Market Dynamics 18
2.3.1 Liver Disease Diagnostics Industry Trends 18
2.3.2 Liver Disease Diagnostics Market Drivers 19
2.3.3 Liver Disease Diagnostics Market Challenges 20
2.3.4 Liver Disease Diagnostics Market Restraints 20
3 Competition Landscape by Key Players 21
3.1 Global Revenue Liver Disease Diagnostics by Players 21
3.1.1 Global Liver Disease Diagnostics Revenue by Players (2018-2023) 21
3.1.2 Global Liver Disease Diagnostics Revenue Market Share by Players (2018-2023) 22
3.2 Global Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 23
3.3 Global Key Players of Liver Disease Diagnostics, Ranking by Revenue 24
3.4 Global Liver Disease Diagnostics Market Concentration Ratio 25
3.4.1 Global Liver Disease Diagnostics Market Concentration Ratio (CR5 and HHI) 25
3.4.2 Global Top 10 and Top 5 Companies by Liver Disease Diagnostics Revenue in 2022 26
3.5 Global Key Players of Liver Disease Diagnostics Head office and Manufacturing Sites 27
3.6 Global Key Players of Liver Disease Diagnostics Product 28
3.7 Global Key Players of Liver Disease Diagnostics, Founded Date 28
3.8 Mergers & Acquisitions, Expansion Plans 29
4 Liver Disease Diagnostics Breakdown Data by Type 32
4.1 Global Liver Disease Diagnostics Historic Market Size by Type (2018-2023) 32
4.2 Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029) 33
5 Liver Disease Diagnostics Breakdown Data by Application 34
5.1 Global Liver Disease Diagnostics Historic Market Size by Application (2018-2023) 34
5.2 Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029) 35
6 North America 36
6.1 North America Liver Disease Diagnostics Market Size (2018-2029) 36
6.2 North America Liver Disease Diagnostics Market Size by Type 36
6.2.1 North America Liver Disease Diagnostics Market Size by Type (2018-2023) 36
6.2.2 North America Liver Disease Diagnostics Market Size by Type (2024-2029) 37
6.2.3 North America Liver Disease Diagnostics Market Share by Type (2018-2029) 37
6.3 North America Liver Disease Diagnostics Market Size by Application 38
6.3.1 North America Liver Disease Diagnostics Market Size by Application (2018-2023) 38
6.3.2 North America Liver Disease Diagnostics Market Size by Application (2024-2029) 38
6.3.3 North America Liver Disease Diagnostics Market Share by Application (2018-2029) 39
6.4 North America Liver Disease Diagnostics Market Size by Country 39
6.4.1 North America Liver Disease Diagnostics Market Size by Country (2018-2023) 39
6.4.2 North America Liver Disease Diagnostics Market Share by Country (2024-2029) 40
6.4.3 United States 41
6.4.4 Canada 41
6.4.5 Mexico 42
7 Europe 43
7.1 Europe Liver Disease Diagnostics Market Size (2018-2029) 43
7.2 Europe Liver Disease Diagnostics Market Size by Type 43
7.2.1 Europe Liver Disease Diagnostics Market Size by Type (2018-2023) 43
7.2.2 Europe Liver Disease Diagnostics Market Size by Type (2024-2029) 44
7.2.3 Europe Liver Disease Diagnostics Market Share by Type (2018-2029) 44
7.3 Europe Liver Disease Diagnostics Market Size by Application 45
7.3.1 Europe Liver Disease Diagnostics Market Size by Application (2018-2023) 45
7.3.2 Europe Liver Disease Diagnostics Market Size by Application (2024-2029) 45
7.3.3 Europe Liver Disease Diagnostics Market Share by Application (2018-2029) 46
7.4 Europe Liver Disease Diagnostics Market Size by Country 46
7.4.1 Europe Liver Disease Diagnostics Market Size by Country (2018-2023) 46
7.4.2 Europe Liver Disease Diagnostics Market Size by Country (2024-2029) 47
7.4.3 Germany 48
7.4.4 France 48
7.4.5 U.K. 49
7.4.6 Italy 49
7.4.7 Switzerland 50
8 Asia Pacific 51
8.1 Asia Pacific Liver Disease Diagnostics Market Size (2018-2029) 51
8.2 Asia Pacific Liver Disease Diagnostics Market Size by Type 51
8.2.1 Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023) 51
8.2.2 Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029) 52
8.2.3 Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029) 52
8.3 Asia Pacific Liver Disease Diagnostics Market Size by Application 53
8.3.1 Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023) 53
8.3.2 Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029) 53
8.3.3 Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029) 54
8.4 Asia Pacific Liver Disease Diagnostics Market Size by Region 54
8.4.1 Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023) 54
8.4.2 Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029) 55
8.4.3 China 56
8.4.4 Japan 56
8.4.5 South Korea 57
8.4.6 Southeast Asia 58
8.4.7 India 58
8.4.8 Australia 59
9 Latin America 60
9.1 Latin America Liver Disease Diagnostics Market Size (2018-2029) 60
9.2 Latin America Liver Disease Diagnostics Market Size by Type 60
9.2.1 Latin America Liver Disease Diagnostics Market Size by Type (2018-2023) 60
9.2.2 Latin America Liver Disease Diagnostics Market Size by Type (2024-2029) 61
9.2.3 Latin America Liver Disease Diagnostics Market Share by Type (2018-2029) 61
9.3 Latin America Liver Disease Diagnostics Market Size by Application 62
9.3.1 Latin America Liver Disease Diagnostics Market Size by Application (2018-2023) 62
9.3.2 Latin America Liver Disease Diagnostics Market Size by Application (2024-2029) 62
9.3.3 Latin America Liver Disease Diagnostics Market Share by Application (2018-2029) 63
9.4 Latin America Liver Disease Diagnostics Market Size by Country 63
9.4.1 Latin America Liver Disease Diagnostics Market Size by Country (2018-2023) 63
9.4.2 Latin America Liver Disease Diagnostics Market Size by Country (2024-2029) 64
9.4.3 Brazil 65
9.4.4 Argentina 65
10 Middle East & Africa 66
10.1 Middle East & Africa Liver Disease Diagnostics Market Size (2018-2029) 66
10.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type 66
10.2.1 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023) 66
10.2.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029) 67
10.2.3 Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029) 68
10.3 Middle East & Africa Liver Disease Diagnostics Market Size by Application 68
10.3.1 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023) 68
10.3.2 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029) 69
10.3.3 Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029) 69
10.4 Middle East & Africa Liver Disease Diagnostics Market Size by Country 70
10.4.1 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023) 70
10.4.2 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029) 70
10.4.3 Saudi Arabia 71
10.4.4 UAE 72
10.4.5 Israel 72
11 Key Players Profiles 73
11.1 Abbott 73
11.1.1 Abbott Company Details 73
11.1.2 Abbott Business Overview 73
11.1.3 Abbott Liver Disease Diagnostics Introduction 74
11.1.4 Abbott Revenue in Liver Disease Diagnostics Business (2018-2023) 76
11.1.5 Abbott Recent Development 77
11.2 Roche 77
11.2.1 Roche Company Details 78
11.2.2 Roche Business Overview 78
11.2.3 Roche Liver Disease Diagnostics Introduction 79
11.2.4 Roche Revenue in Liver Disease Diagnostics Business (2018-2023) 80
11.2.5 Roche Recent Development 81
11.3 Thermo Fisher Scientific 81
11.3.1 Thermo Fisher Scientific Company Details 81
11.3.2 Thermo Fisher Scientific Business Overview 82
11.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Introduction 82
11.3.4 Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023) 85
11.4 Randox Diagnostic Centers 86
11.4.1 Randox Diagnostic Centers Company Details 86
11.4.2 Randox Diagnostic Centers Business Overview 87
11.4.3 Randox Diagnostic Centers Liver Disease Diagnostics Introduction 87
11.4.4 Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023) 89
11.4.5 Randox Diagnostic Centers Recent Development 90
11.5 Boston Scientific Corporation 90
11.5.1 Boston Scientific Corporation Company Details 91
11.5.2 Boston Scientific Corporation Business Overview 91
11.5.3 Boston Scientific Corporation Liver Disease Diagnostics Introduction 92
11.5.4 Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 94
11.6 LabCorp 94
11.6.1 LabCorp Company Details 95
11.6.2 LabCorp Business Overview 95
11.6.3 LabCorp Liver Disease Diagnostics Introduction 96
11.6.4 LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023) 96
11.6.5 LabCorp Recent Development 97
11.7 Fujifilm Corporation 98
11.7.1 Fujifilm Corporation Company Details 98
11.7.2 Fujifilm Corporation Business Overview 98
11.7.3 Fujifilm Corporation Liver Disease Diagnostics Introduction 99
11.7.4 Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 100
11.8 Siemens Healthineers 101
11.8.1 Siemens Healthineers Company Details 101
11.8.2 Siemens Healthineers Business Overview 102
11.8.3 Siemens Healthineers Liver Disease Diagnostics Introduction 102
11.8.4 Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023) 104
11.9 BD 104
11.9.1 BD Company Details 105
11.9.2 BD Business Overview 105
11.9.3 BD Liver Disease Diagnostics Introduction 106
11.9.4 BD Revenue in Liver Disease Diagnostics Business (2018-2023) 106
11.10 Cook Medical 107
11.10.1 Cook Medical Company Details 107
11.10.2 Cook Medical Business Overview 108
11.10.3 Cook Medical Liver Disease Diagnostics Introduction 108
11.10.4 Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023) 110
11.11 GE Healthcare 110
11.11.1 GE Healthcare Company Details 111
11.11.2 GE Healthcare Business Overview 111
11.11.3 GE Healthcare Liver Disease Diagnostics Introduction 112
11.11.4 GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 113
11.12 Philips Healthcare 113
11.12.1 Philips Healthcare Company Details 114
11.12.2 Philips Healthcare Business Overview 114
11.12.3 Philips Healthcare Liver Disease Diagnostics Introduction 115
11.12.4 Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 115
11.12.5 Philips Healthcare Recent Development 116
11.13 Canon Medical Systems 116
11.13.1 Canon Medical Systems Company Details 117
11.13.2 Canon Medical Systems Business Overview 117
11.13.3 Canon Medical Systems Liver Disease Diagnostics Introduction 117
11.13.4 Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023) 118
11.13.5 Canon Medical Systems Recent Development 119
11.14 Qiagen 119
11.14.1 Qiagen Company Details 120
11.14.2 Qiagen Business Overview 120
11.14.3 Qiagen Liver Disease Diagnostics Introduction 121
11.14.4 Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023) 122
12 Analyst's Viewpoints/Conclusions 123
13 Appendix 125
13.1 Research Methodology 125
13.1.1 Methodology/Research Approach 125
13.1.2 Data Source 128
13.2 Author Details 131
13.3 Disclaimer 133

 

ページTOPに戻る


 

Summary

The global Liver Disease Diagnostics market is projected to grow from US$ 13,361.64 million in 2023 to US$ 20,102.98 million by 2029, at a Compound Annual Growth Rate (CAGR) of 7.05% during the forecast period.
North America Liver Disease Diagnostics market size is valued at US$ 5,019.20 million in 2022, while Asia Pacific and Europe Liver Disease Diagnostics are US$ 3,036.97 million and US$ 3,690.05 million, severally. The proportion of the North America is 40.95% in 2022, while APAC and Europe are 24.78% and 30.11% respectively, and it is predicted that APAC proportion will reach 28.57% in 2029, trailing a CAGR of 8.99% through the analysis period. China, Japan, South Korea, and India are noteworthy markets in APAC. As for the Europe Liver Disease Diagnostics landscape, Germany is projected to reach US$ 1,292.90 million by 2029 trailing a CAGR of 6.06% during 2023-2029.

The global key companies of Liver Disease Diagnostics include Roche, Abbott, Thermo Fisher Scientific, Siemens Healthineers, GE Healthcare, Canon Medical Systems, LabCorp, BD, Philips Healthcare and Randox Laboratories is the leading manufacturer in global Liver Disease Diagnostics market. The top 10 listed companies accounted for 39.41% of the market share in 2022 in terms of revenue.

Report Includes
This report presents an overview of global market for Liver Disease Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Liver Disease Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Disease Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Disease Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Disease Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Disease Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Roche, Thermo Fisher Scientific, Randox Diagnostic Centers, Boston Scientific Corporation, LabCorp, Fujifilm Corporation, Horiba Medical, and Siemens Healthineers, etc.

By Company
Abbott
Roche
Thermo Fisher Scientific
Randox Laboratories
Boston Scientific
LabCorp
Fujifilm Corporation
Siemens Healthineers
BD
Cook Medical
GE Healthcare
Philips Healthcare
Canon Medical Systems
Qiagen

Segment by Type
Imaging Tests
Blood Tests
Biopsy

Segment by Application
Hospitals and Clinics
Diagnostic Centers
Others

By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Switzerland
Rest of Europe
Latin America
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Saudi Arabia
UAE
Israel
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Liver Disease Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1
1.2.2 Imaging Tests 3
1.2.3 Blood Tests 4
1.2.4 Biopsy 5
1.3 Market by Application 6
1.3.1 Global Liver Disease Diagnostics Market Share by Application: 2018 VS 2022 VS 2029 6
1.3.2 Hospitals and Clinics 8
1.3.3 Diagnostic Centers 9
1.3.4 Others 9
1.4 Assumptions and Limitations 10
1.5 Study Objectives 11
1.6 Years Considered 11
2 Global Growth Trends 13
2.1 Global Liver Disease Diagnostics Market Perspective (2018-2029) 13
2.2 Global Liver Disease Diagnostics Growth Trends by Region 14
2.2.1 Global Liver Disease Diagnostics Market Size by Region: 2018 VS 2022 VS 2029 15
2.2.2 Liver Disease Diagnostics Historic Market Size by Region (2018-2023) 16
2.2.3 Liver Disease Diagnostics Forecasted Market Size by Region (2024-2029) 17
2.3 Liver Disease Diagnostics Market Dynamics 18
2.3.1 Liver Disease Diagnostics Industry Trends 18
2.3.2 Liver Disease Diagnostics Market Drivers 19
2.3.3 Liver Disease Diagnostics Market Challenges 20
2.3.4 Liver Disease Diagnostics Market Restraints 20
3 Competition Landscape by Key Players 21
3.1 Global Revenue Liver Disease Diagnostics by Players 21
3.1.1 Global Liver Disease Diagnostics Revenue by Players (2018-2023) 21
3.1.2 Global Liver Disease Diagnostics Revenue Market Share by Players (2018-2023) 22
3.2 Global Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 23
3.3 Global Key Players of Liver Disease Diagnostics, Ranking by Revenue 24
3.4 Global Liver Disease Diagnostics Market Concentration Ratio 25
3.4.1 Global Liver Disease Diagnostics Market Concentration Ratio (CR5 and HHI) 25
3.4.2 Global Top 10 and Top 5 Companies by Liver Disease Diagnostics Revenue in 2022 26
3.5 Global Key Players of Liver Disease Diagnostics Head office and Manufacturing Sites 27
3.6 Global Key Players of Liver Disease Diagnostics Product 28
3.7 Global Key Players of Liver Disease Diagnostics, Founded Date 28
3.8 Mergers & Acquisitions, Expansion Plans 29
4 Liver Disease Diagnostics Breakdown Data by Type 32
4.1 Global Liver Disease Diagnostics Historic Market Size by Type (2018-2023) 32
4.2 Global Liver Disease Diagnostics Forecasted Market Size by Type (2024-2029) 33
5 Liver Disease Diagnostics Breakdown Data by Application 34
5.1 Global Liver Disease Diagnostics Historic Market Size by Application (2018-2023) 34
5.2 Global Liver Disease Diagnostics Forecasted Market Size by Application (2024-2029) 35
6 North America 36
6.1 North America Liver Disease Diagnostics Market Size (2018-2029) 36
6.2 North America Liver Disease Diagnostics Market Size by Type 36
6.2.1 North America Liver Disease Diagnostics Market Size by Type (2018-2023) 36
6.2.2 North America Liver Disease Diagnostics Market Size by Type (2024-2029) 37
6.2.3 North America Liver Disease Diagnostics Market Share by Type (2018-2029) 37
6.3 North America Liver Disease Diagnostics Market Size by Application 38
6.3.1 North America Liver Disease Diagnostics Market Size by Application (2018-2023) 38
6.3.2 North America Liver Disease Diagnostics Market Size by Application (2024-2029) 38
6.3.3 North America Liver Disease Diagnostics Market Share by Application (2018-2029) 39
6.4 North America Liver Disease Diagnostics Market Size by Country 39
6.4.1 North America Liver Disease Diagnostics Market Size by Country (2018-2023) 39
6.4.2 North America Liver Disease Diagnostics Market Share by Country (2024-2029) 40
6.4.3 United States 41
6.4.4 Canada 41
6.4.5 Mexico 42
7 Europe 43
7.1 Europe Liver Disease Diagnostics Market Size (2018-2029) 43
7.2 Europe Liver Disease Diagnostics Market Size by Type 43
7.2.1 Europe Liver Disease Diagnostics Market Size by Type (2018-2023) 43
7.2.2 Europe Liver Disease Diagnostics Market Size by Type (2024-2029) 44
7.2.3 Europe Liver Disease Diagnostics Market Share by Type (2018-2029) 44
7.3 Europe Liver Disease Diagnostics Market Size by Application 45
7.3.1 Europe Liver Disease Diagnostics Market Size by Application (2018-2023) 45
7.3.2 Europe Liver Disease Diagnostics Market Size by Application (2024-2029) 45
7.3.3 Europe Liver Disease Diagnostics Market Share by Application (2018-2029) 46
7.4 Europe Liver Disease Diagnostics Market Size by Country 46
7.4.1 Europe Liver Disease Diagnostics Market Size by Country (2018-2023) 46
7.4.2 Europe Liver Disease Diagnostics Market Size by Country (2024-2029) 47
7.4.3 Germany 48
7.4.4 France 48
7.4.5 U.K. 49
7.4.6 Italy 49
7.4.7 Switzerland 50
8 Asia Pacific 51
8.1 Asia Pacific Liver Disease Diagnostics Market Size (2018-2029) 51
8.2 Asia Pacific Liver Disease Diagnostics Market Size by Type 51
8.2.1 Asia Pacific Liver Disease Diagnostics Market Size by Type (2018-2023) 51
8.2.2 Asia Pacific Liver Disease Diagnostics Market Size by Type (2024-2029) 52
8.2.3 Asia Pacific Liver Disease Diagnostics Market Share by Type (2018-2029) 52
8.3 Asia Pacific Liver Disease Diagnostics Market Size by Application 53
8.3.1 Asia Pacific Liver Disease Diagnostics Market Size by Application (2018-2023) 53
8.3.2 Asia Pacific Liver Disease Diagnostics Market Size by Application (2024-2029) 53
8.3.3 Asia Pacific Liver Disease Diagnostics Market Share by Application (2018-2029) 54
8.4 Asia Pacific Liver Disease Diagnostics Market Size by Region 54
8.4.1 Asia Pacific Liver Disease Diagnostics Market Size by Region (2018-2023) 54
8.4.2 Asia Pacific Liver Disease Diagnostics Market Size by Region (2024-2029) 55
8.4.3 China 56
8.4.4 Japan 56
8.4.5 South Korea 57
8.4.6 Southeast Asia 58
8.4.7 India 58
8.4.8 Australia 59
9 Latin America 60
9.1 Latin America Liver Disease Diagnostics Market Size (2018-2029) 60
9.2 Latin America Liver Disease Diagnostics Market Size by Type 60
9.2.1 Latin America Liver Disease Diagnostics Market Size by Type (2018-2023) 60
9.2.2 Latin America Liver Disease Diagnostics Market Size by Type (2024-2029) 61
9.2.3 Latin America Liver Disease Diagnostics Market Share by Type (2018-2029) 61
9.3 Latin America Liver Disease Diagnostics Market Size by Application 62
9.3.1 Latin America Liver Disease Diagnostics Market Size by Application (2018-2023) 62
9.3.2 Latin America Liver Disease Diagnostics Market Size by Application (2024-2029) 62
9.3.3 Latin America Liver Disease Diagnostics Market Share by Application (2018-2029) 63
9.4 Latin America Liver Disease Diagnostics Market Size by Country 63
9.4.1 Latin America Liver Disease Diagnostics Market Size by Country (2018-2023) 63
9.4.2 Latin America Liver Disease Diagnostics Market Size by Country (2024-2029) 64
9.4.3 Brazil 65
9.4.4 Argentina 65
10 Middle East & Africa 66
10.1 Middle East & Africa Liver Disease Diagnostics Market Size (2018-2029) 66
10.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type 66
10.2.1 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2018-2023) 66
10.2.2 Middle East & Africa Liver Disease Diagnostics Market Size by Type (2024-2029) 67
10.2.3 Middle East & Africa Liver Disease Diagnostics Market Share by Type (2018-2029) 68
10.3 Middle East & Africa Liver Disease Diagnostics Market Size by Application 68
10.3.1 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2018-2023) 68
10.3.2 Middle East & Africa Liver Disease Diagnostics Market Size by Application (2024-2029) 69
10.3.3 Middle East & Africa Liver Disease Diagnostics Market Share by Application (2018-2029) 69
10.4 Middle East & Africa Liver Disease Diagnostics Market Size by Country 70
10.4.1 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2018-2023) 70
10.4.2 Middle East & Africa Liver Disease Diagnostics Market Size by Country (2024-2029) 70
10.4.3 Saudi Arabia 71
10.4.4 UAE 72
10.4.5 Israel 72
11 Key Players Profiles 73
11.1 Abbott 73
11.1.1 Abbott Company Details 73
11.1.2 Abbott Business Overview 73
11.1.3 Abbott Liver Disease Diagnostics Introduction 74
11.1.4 Abbott Revenue in Liver Disease Diagnostics Business (2018-2023) 76
11.1.5 Abbott Recent Development 77
11.2 Roche 77
11.2.1 Roche Company Details 78
11.2.2 Roche Business Overview 78
11.2.3 Roche Liver Disease Diagnostics Introduction 79
11.2.4 Roche Revenue in Liver Disease Diagnostics Business (2018-2023) 80
11.2.5 Roche Recent Development 81
11.3 Thermo Fisher Scientific 81
11.3.1 Thermo Fisher Scientific Company Details 81
11.3.2 Thermo Fisher Scientific Business Overview 82
11.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Introduction 82
11.3.4 Thermo Fisher Scientific Revenue in Liver Disease Diagnostics Business (2018-2023) 85
11.4 Randox Diagnostic Centers 86
11.4.1 Randox Diagnostic Centers Company Details 86
11.4.2 Randox Diagnostic Centers Business Overview 87
11.4.3 Randox Diagnostic Centers Liver Disease Diagnostics Introduction 87
11.4.4 Randox Diagnostic Centers Revenue in Liver Disease Diagnostics Business (2018-2023) 89
11.4.5 Randox Diagnostic Centers Recent Development 90
11.5 Boston Scientific Corporation 90
11.5.1 Boston Scientific Corporation Company Details 91
11.5.2 Boston Scientific Corporation Business Overview 91
11.5.3 Boston Scientific Corporation Liver Disease Diagnostics Introduction 92
11.5.4 Boston Scientific Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 94
11.6 LabCorp 94
11.6.1 LabCorp Company Details 95
11.6.2 LabCorp Business Overview 95
11.6.3 LabCorp Liver Disease Diagnostics Introduction 96
11.6.4 LabCorp Revenue in Liver Disease Diagnostics Business (2018-2023) 96
11.6.5 LabCorp Recent Development 97
11.7 Fujifilm Corporation 98
11.7.1 Fujifilm Corporation Company Details 98
11.7.2 Fujifilm Corporation Business Overview 98
11.7.3 Fujifilm Corporation Liver Disease Diagnostics Introduction 99
11.7.4 Fujifilm Corporation Revenue in Liver Disease Diagnostics Business (2018-2023) 100
11.8 Siemens Healthineers 101
11.8.1 Siemens Healthineers Company Details 101
11.8.2 Siemens Healthineers Business Overview 102
11.8.3 Siemens Healthineers Liver Disease Diagnostics Introduction 102
11.8.4 Siemens Healthineers Revenue in Liver Disease Diagnostics Business (2018-2023) 104
11.9 BD 104
11.9.1 BD Company Details 105
11.9.2 BD Business Overview 105
11.9.3 BD Liver Disease Diagnostics Introduction 106
11.9.4 BD Revenue in Liver Disease Diagnostics Business (2018-2023) 106
11.10 Cook Medical 107
11.10.1 Cook Medical Company Details 107
11.10.2 Cook Medical Business Overview 108
11.10.3 Cook Medical Liver Disease Diagnostics Introduction 108
11.10.4 Cook Medical Revenue in Liver Disease Diagnostics Business (2018-2023) 110
11.11 GE Healthcare 110
11.11.1 GE Healthcare Company Details 111
11.11.2 GE Healthcare Business Overview 111
11.11.3 GE Healthcare Liver Disease Diagnostics Introduction 112
11.11.4 GE Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 113
11.12 Philips Healthcare 113
11.12.1 Philips Healthcare Company Details 114
11.12.2 Philips Healthcare Business Overview 114
11.12.3 Philips Healthcare Liver Disease Diagnostics Introduction 115
11.12.4 Philips Healthcare Revenue in Liver Disease Diagnostics Business (2018-2023) 115
11.12.5 Philips Healthcare Recent Development 116
11.13 Canon Medical Systems 116
11.13.1 Canon Medical Systems Company Details 117
11.13.2 Canon Medical Systems Business Overview 117
11.13.3 Canon Medical Systems Liver Disease Diagnostics Introduction 117
11.13.4 Canon Medical Systems Revenue in Liver Disease Diagnostics Business (2018-2023) 118
11.13.5 Canon Medical Systems Recent Development 119
11.14 Qiagen 119
11.14.1 Qiagen Company Details 120
11.14.2 Qiagen Business Overview 120
11.14.3 Qiagen Liver Disease Diagnostics Introduction 121
11.14.4 Qiagen Revenue in Liver Disease Diagnostics Business (2018-2023) 122
12 Analyst's Viewpoints/Conclusions 123
13 Appendix 125
13.1 Research Methodology 125
13.1.1 Methodology/Research Approach 125
13.1.2 Data Source 128
13.2 Author Details 131
13.3 Disclaimer 133

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る